echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The big health industry has ushered in a "golden period" of development, and pharmaceutical companies are accelerating their layout

    The big health industry has ushered in a "golden period" of development, and pharmaceutical companies are accelerating their layout

    • Last Update: 2023-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Great health is a global health concept proposed in response to the development of the times, social needs and changes in the disease spectrum, the industry has a strong development momentum and huge market potential
    .
    It is worth mentioning that with the implementation of the "Healthy China Action (2019-2030)", under the background that health management has risen to the national strategic level in China, the industry believes that the scale of the large health industry will grow
    by order of magnitude.

     
    Incomplete statistics show that the market size of the large health industry has reached 7 trillion yuan in 2020, and under the background of the support of many favorable policies and the continuous increase of capital, it is predicted that the market will exceed 8 trillion yuan
    in 2022.

     
    The development and growth of the industry is inseparable from the favorable and promoted
    policies.
    It is reported that at a time when the big health market is expanding and the concept of big health has been deeply rooted in the hearts of the people, China has been focusing on the development of the big health industry and has been constantly introducing policy measures
    .
    For example, the "Several Measures to Support the High-quality Development of the Biomedical Health Industry in the Guangdong-Macao Intensive Cooperation Zone in Hengqin" (hereinafter referred to as the "Several Measures") was officially promulgated
    on October 31.
    The "Certain Measures" vigorously supports the development of Macao's brand industry of traditional Chinese medicine, accelerates the development of a large health industry with the R&D and manufacturing of traditional Chinese medicine as the starting point, and strives to promote the construction of a new highland of the world-class biomedical health industry with distinctive characteristics, which has injected new vitality
    into the moderate diversification of Macao's economy.

     
    In addition, in order to further implement the national decision-making and deployment of the development of the health industry, seize the opportunity, accelerate the cultivation and expansion of the health industry in Guizhou, and promote its healthy and rapid development, Guizhou Province has also compiled the "14th Five-Year Plan for the Development of the Great Health Industry in Guizhou Province"
    .
    The plan proposes that by 2025, the added value of the province's large health industry will account for more than 15%
    of GDP.

     
    Out of optimism about the development of the big health industry, a large number of pharmaceutical companies are also focusing on this field, and are promoting the rapid development
    of the big health industry through a large number of new technologies and project research and development.

     
    For example, recently, 9 TCM health industry projects have settled in Huicheng District, Boluo County, Longmen County and Zhongkai High-tech Zone, with a total investment of 8.
    15 billion yuan
    。 It is understood that the 9 Chinese medicine health industry projects signed this time are Luofu Chinese Medicine Traditional Chinese Medicine Industry Project, Huizhou Industry and Investment, China Resources Sanjiu Strategic Cooperation Project, Xinrui Medical Technology Industry Project, Deda Medical Project, Rongshi Hai Electronic Medical Equipment Intelligent Manufacturing Project, etc.
    , involving traditional Chinese medicine pharmaceutical, biomedical materials, intelligent manufacturing of medical equipment, planting and processing of Chinese medicinal materials, production of medicinal and food homologous beverages, health tourism complex and other life and health tertiary industries and research and development fields.
    It will effectively promote the integrated development of
    "production, education and research" in the traditional Chinese medicine health industry in Huizhou and even the Guangdong-Hong Kong-Macao Greater Bay Area.

     
    On May 6, China Resources Pharmaceutical, China Resources Sanjiu signed a strategic cooperation agreement and a share transfer agreement
    with Holley Pharmaceutical, a wholly-owned subsidiary of Holley Group.
    According to the agreement, the three parties will carry out comprehensive strategic cooperation in traditional Chinese medicine, health industry and other related industries to jointly expand the global market
    .
    According to reports, the signing will play a positive role
    in promoting the cooperation parties to improve the industrial layout, improve the efficiency of resource allocation, and enhance competitiveness.

     
    On April 19, Huahai Pharmaceutical newly established Zhejiang Freeze-Dryer Technology Co.
    , Ltd.
    , with a registered capital of 10 million, which is wholly-owned by Huahai Health Technology (Zhejiang) Co.
    , Ltd.
    , a wholly-owned subsidiary of Huahai Pharmaceutical, is a scientific and technological innovation company in the field of large health, and its business scope includes technology development and promotion; food sales; Health food (pre-packaged) sales, etc
    .

     
    On the whole, the layout of the big health industry has become one of the trends in the
    pharmaceutical industry.
    Industry analysts believe that under the influence of increasingly perfect policies, China's economic growth and consumption capacity, and the continuous intensification of medical care caused by population aging, the big health industry will accelerate its development in China and is expected to become a new growth point
    of the national economy.

     
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.